# Mefenamic Acid

## Ponstan 250mg

| TAH Drug Code      | [OPON](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OPON                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Mild to moderate pain, RA, osteoarthritis, dysmenorrhea, menorrhagia, Still's disease, pyrexia.                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Adult and teenagers >14 years old: 500 mg TID. Still's Disease or antipyretic therapy for children of 6 months to 14 years old: 19.5-25mg/kg/day divided into 3 doses.                                                                                                                                                                                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Patients in whom aspirin and/or other NSAIDs have induced symptoms of bronchospasm, allergic rhinitis or urticaria. Active ulceration or chronic inflammation of GIT. Kidney disease. Treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Severe renal, hepatic & heart failure.                                                                                                                                                                                                                             |
| Adverse Effects    | Hematologic disorders; hypersensitivity reactions; glucose intolerance in diabetic patients, hyponatremia; nervousness; aseptic meningitis, blurred vision, convulsion, dizziness, drowsiness, headache, insomnia; eye irritation, reversible loss of color vision; ear pain; palpitation; hypotension; asthma, dyspnea; abdominal pain, diarrhea, nausea with or without vomiting; skin & SC tissue disorders; dysuria, hematuria, renal failure including papillary necrosis. Cardiovascular: Edema Hepatic: Increased liver function test (up to 15%) |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mefenamic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

